You are here: Home / News Release Archives / 2011 / May / Garber VC Fund Invests in Philadelphia Medical Imaging Technology Firm

Garber VC Fund Invests in Philadelphia Medical Imaging Technology Firm

The Garber Venture Capital Fund, an MBA student-centric VC fund at the Penn State Smeal College of Business, recently closed a transaction to invest $150,000 in Real Time Tomography (RTT), LLC, a medical imaging technology firm based in suburban Philadelphia.
May 10, 2011


The Garber Venture Capital Fund, an MBA student-centric VC fund at the Penn State Smeal College of Business, recently closed a transaction to invest $150,000 in Real Time Tomography (RTT), LLC, a medical imaging technology firm based in suburban Philadelphia.

The Garber Fund invests in early stage companies with a focus on information technology, life sciences and other highly scalable business models. Used within a course environment, the fund allows Smeal MBA students to experience firsthand all aspects of venture capital investing.

MBA students become general partners in the fund by enrolling in the Garber Practicum entrepreneurship course (ENTR 503) in the Smeal MBA Program. Entrepreneurs from several prospective investment properties visit the class each semester to present their business concepts to the fund partners. Student teams then perform due diligence on the firms and select one or two for more detailed analysis.

Toward the end of the seminar, the teams present their findings to their peers, who vote on which, if any, properties warrant an investment. The decision process includes which investment vehicle is most appropriate (debt or equity), the amount of the investment, and other issues including warrant coverage, valuation, discounts, and tranches or milestones that trigger additional investment.

The Garber Fund's investment in Real Time Tomography will help the firm to further develop its medical imaging technology for early breast cancer detection. RTT develops state-of-the-art image processing and reconstruction solutions for next-generation medical imaging systems. Its patent-pending Dynamic Reconstruction and Rendering technology will advance digital breast tomosynthesis—a new 3D imaging medium for the early detection of breast cancer—and provide radiologists with greater and more efficient capabilities to interpret image data for more accurate diagnosis.

"I am delighted that the Garber Fund recognizes that Real Time Tomography's innovative technologies will improve the fight against breast cancer while helping to keep health care costs down," said Susan Ng, chief executive officer of RTT. "Digital breast tomosynthesis will be the next gold-standard in breast cancer detection and RTT is at the forefront in its development. This investment will enable RTT to further develop and market its imaging products and to examine its technology for other applications, such as body tomosynthesis."

The Garber Fund's two-tranche investment of $150,000 will fund the completion of RTT's Adara Net Appliance, a clinical network appliance that receives, processes and transmits mammograms. The Adara Net Appliance enhances mammography images for improved radiologist review and more accurate diagnosis.

About the Garber Venture Capital Fund
The Garber Fund was established in 1999 with a $5 million commitment from Penn State alumnus John Garber and his wife Bette to bring reality to the teaching of entrepreneurship and venture capital. Since July 2002, the fund has made eight investments and currently has three other active investments, in addition to Real Time Tomography: Diamond Back Truck Accessories, a manufacturer and distributor of pick-up truck covers and other truck accessories, Healthy Humans LLC, a provider of e-health portals for patients and doctors to improve health outcomes and lower costs, and INDIGO Biosciences, which has developed a unique method to cryogenically preserve nuclear receptor cells.

For more information, contact David Lipson, director of the Garber Venture Capital Fund, at 814-865-0195.

About Real Time Tomography
Real Time Tomography develops state-of-the-art image processing and reconstruction solutions for next-generation 2D and 3D imaging systems. Its mission is to save lives and reduce health care costs by developing technically innovative products that improve diagnostic accuracy and clinical workflow. RTT's imaging products are easy-to-integrate solutions available to manufacturers of medical imaging systems, helping them to reduce development costs and accelerate their time to market.

For more information on Real Time Tomography, visit www.realtimetomography.com.

Recent News
Loss aversion drives consumers to purchase high-priced extended warranties 23 Jan

Pranav Jindal, assistant professor of marketing at the Penn State Smeal College of Business, has published a research paper that examines why consumers purchase extended warranties.

Smeal using assessment to influence student leadership training 23 Jan

With ample evidence that employers seek students with effective leadership skills, the Office of Career and Corporate Connections at the Penn State Smeal College of Business is steadily expanding the use of the Korn/Ferry ProSpective Leadership Assessment to influence programming and increase undergraduate student marketability.

Executive Insights: PwC Vice Chairman Mitch Cohen to Speak at Smeal Leadership Lecture Series 20 Jan Executive Insights: PwC Vice Chairman Mitch Cohen to Speak at Smeal Leadership Lecture Series

Mitch Cohen ’81 ACCTG, vice chairman of PricewaterhouseCoopers LLP (PwC), will share his perspectives on business, leadership, and a book he recently co-authored, with the Penn State Smeal College of Business on Friday, Feb. 13.

Smeal names Mooney director of eLDIG 09 Jan Smeal names Mooney director of eLDIG

The Penn State Smeal College of Business has named Matthew E. Mooney director of the college’s new eLearning Design and Innovation Group (eLDIG).

New Smeal Major Aligns with ‘Culture of Entrepreneurship’ at Penn State 06 Jan

The Penn State Smeal College of Business will add to its roster of majors for undergraduate students and expand its portfolio of entrepreneurship-related initiatives with the launch this semester of a new Corporate Innovation and Entrepreneurship (CIENT) major.

More Recent News... More Recent News...